Spots Global Cancer Trial Database for volumetric mri
Every month we try and update this database with for volumetric mri cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Natural History Study of Patients With Neurofibromatosis Type I | NCT00924196 | Neurofibromatos... Malignant Perip... Plexiform Neuro... Optic Glioma Neurofibroma | 4 Weeks - | National Institutes of Health Clinical Center (CC) | ||
Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive Endpoints | NCT05832099 | Intracranial Me... | Radiation | 18 Years - 85 Years | Chang Gung Memorial Hospital | |
Natural History Study of Patients With Neurofibromatosis Type I | NCT00924196 | Neurofibromatos... Malignant Perip... Plexiform Neuro... Optic Glioma Neurofibroma | 4 Weeks - | National Institutes of Health Clinical Center (CC) | ||
Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 | NCT00006435 | Plexiform Neuro... NF1 | - 100 Years | National Institutes of Health Clinical Center (CC) | ||
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas | NCT02407405 | Neurofibromatos... Plexiform Neuro... | Selumetinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas | NCT02407405 | Neurofibromatos... Plexiform Neuro... | Selumetinib | 18 Years - | National Institutes of Health Clinical Center (CC) |